Explorer les evidences

Palier Gold : evidences validées mécaniquement, avec leur source primaire.

298 evidences · page 2 / 12

87,5 %Squamous cell carcinoma was the prevalent histologic type in 87.5% of cases.

Nigeriacancer du col de l'utéruspublié 2025BrachytherapyPubMeddocument de 8 observations

62,1 %Of those who had heard of cervical cancer, 62.1% were aware that it could be prevented.

Nigeriacancer du col de l'utéruspublié 2020The Pan African medical journalPubMeddocument de 5 observations

0,49 ORRelative to Phase-2, knowledge changes at Phase-4 for questions associated with the myth 'enemy poisons' were reversed, with an odds ratio of 0.49 (95% CI: 0.37–0.65).

Nigeriacancer du col de l'utéruspublié 2022BMC public healthPubMeddocument de 13 observations

94,4 %Support for cervical cancer screening was high at 94.4% among women and male partners in Makurdi, North-Central Nigeria.

Nigeriacancer du col de l'utéruspublié 2025Asian Pacific journal of cancer prevention : APJCPPubMeddocument de 6 observations

HPV16, HPV18, HPV45, HPV51, and HPV52 were the predominant high-risk HPV genotypes detected in both single and multiple HPV infections in cervical cancer tissues from Maiduguri, Nigeria, during 2013–2015.

Nigeriacancer du col de l'utérusobservé 2013-2015publié 2019The Pan African medical journalPubMeddocument de 4 observations

27 casesAmong 168 pregnant women in Otukpo metropolis, 27 (16.1%) have undergone recommended checkup for human papilloma virus/cervical cancer.

Nigeriacancer du col de l'utérus · human papilloma viruspublié 2024Ethiopian journal of health sciencesPubMeddocument de 7 observations

The mean knowledge score of cervical cancer in the intervention group increased from 0.0 ± 0.3 at baseline to 15.1 ± 3.7 post-intervention.

Nigeriacancer du col de l'utéruspublié 2022BMC women's healthPubMeddocument de 5 observations

7,2 %Post-intervention, risk factor knowledge improved to 7.2% in the control group.

Nigeriacancer du col de l'utéruspublié 2022West African journal of medicinePubMeddocument de 12 observations

7 %7% (3/43) of art entries included 'nurturers', representing self-regulation addressing stresses linked to having relatives with cervical cancer.

Nigeriacancer du col de l'utéruspublié 2026JMIR formative researchPubMeddocument de 7 observations

161 casesAmong 168 pregnant women in Otukpo metropolis, 161 (95.8%) demonstrated poor practices regarding HPV infection, cervical cancer and vaccination.

Nigeriacancer du col de l'utérus · human papilloma viruspublié 2024Ethiopian journal of health sciencesPubMeddocument de 7 observations

70 %The cervical cancer screening rate has not reached the WHO target of 70%.

Nigeriacancer du col de l'utéruspublié 2023BMC women's healthPubMeddocument de 7 observations

66,67 %The predominant EBRT regimen was 1.8 Gy × 25 fractions in 66.67% of patients.

Nigeriacancer du col de l'utéruspublié 2025BrachytherapyPubMeddocument de 8 observations

33,5 %33.5% of the respondents had encouraged their female partners to screen for cervical cancer.

Nigeriacancer du col de l'utérusobservé 2018publié 2023PloS onePubMeddocument de 14 observations

20,8 %20.8% of the 231 women had basic information on the risk factors of cervical cancer.

Nigeriacancer du col de l'utéruspublié 2021Cancer treatment and research communicationsPubMeddocument de 11 observations

38 yearsOn average, women were first screened for cervical cancer at age 38 at Jos University Teaching Hospital in Nigeria.

Nigeriacancer du col de l'utéruspublié 2024Cancer causes & control : CCCPubMeddocument de 5 observations

9 per_10Over 9 of 10 women in a rural community in Enugu State, Nigeria, were willing to vaccinate their children against cervical cancer.

Nigeriacancer du col de l'utéruspublié 2026Rural and remote healthPubMeddocument de 8 observations

43 %43% of the respondents cited lack of a doctor's request as the most common reason for not having undergone cervical screening.

Nigeriacancer du col de l'utéruspublié 2024African health sciencesPubMeddocument de 5 observations

87,9 %Among 400 female students in tertiary institutions in Imo State, 350 (87.9%) have heard of cervical cancer.

Nigeriacancer du col de l'utéruspublié 2021Journal of community healthPubMeddocument de 9 observations

81 %A high percentage of the respondents, 350 (81.0%), had heard about cervical cancer screening.

Nigeriacancer du col de l'utéruspublié 2023Cancer treatment and research communicationsPubMeddocument de 5 observations

70,4 %70.4% of the female postgraduate students at the University of Ibadan disagreed that cervical cancer is a mild disease.

Nigeriacancer du col de l'utéruspublié 2024BMC women's healthPubMeddocument de 6 observations

48,9 %48.9% of respondents vaccinated their wards to prevent cervical cancer.

Nigeriacancer du col de l'utéruspublié 2024Reproductive healthPubMeddocument de 16 observations

14,6 %Only 14.6% of the female secondary school teachers in Enugu metropolis had taught their students about cervical cancer or HPV vaccines.

Nigeriacancer du col de l'utérusobservé 2017publié 2021The Pan African medical journalPubMeddocument de 7 observations

7,5 %7.5% of the participants strongly agreed that they do not see the need for cervical screening.

Nigeriacancer du col de l'utéruspublié 2023BMC women's healthPubMeddocument de 7 observations

92,9 %A machine learning-based DNA methylation classifier achieved 92.9% sensitivity and 88.6% specificity in predicting cervical cancer risk.

Nigeriacancer du col de l'utéruspublié 2025International journal of cancerPubMeddocument de 3 observations

The mean attitude score of cervical cancer in the intervention group increased from 27.1 ± 0.8 at baseline to 36.5 ± 4.8 post-intervention.

Nigeriacancer du col de l'utéruspublié 2022BMC women's healthPubMeddocument de 5 observations

Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.